VYGR: Voyager Therapeutics, Inc. Stock

by  •  • Comments Off on VYGR: Voyager Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 181.23
Enterprise Value ($M) 106.47
Book Value ($M) 272.70
Book Value / Share 4.93
Price / Book 0.66
NCAV ($M) 164.67
NCAV / Share 2.98
Price / NCAV 1.10

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.25

Liquidity (mrq)
Quick Ratio 6.10
Current Ratio 6.10

Balance Sheet (mrq) ($M)
Current Assets 245.21
Assets 353.24
Liabilities 80.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 80.00
Operating Income -80.51
Net Income -65.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.31
Cash from Investing -94.86
Cash from Financing 114.02

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
1 day ago 13G/A Armistice Capital, Llc 9.85 0.74
04-24 13G/A BlackRock, Inc. 6.40 -35.43
11-14 13G/A EcoR1 Capital, LLC 9.99 45.86

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-11 10-K UNITED STATES
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 35,161 246,331 14.27
2025-05-14 70,452 242,325 29.07
2025-05-13 89,156 381,834 23.35
2025-05-12 102,883 576,090 17.86

(click for more detail)

Similar Companies
VRTX – Vertex Pharmaceuticals Incorporated VTRS – Viatris Inc.
VTYX – Ventyx Biosciences, Inc. XBIT – XBiotech Inc.
XERS – Xeris Biopharma Holdings, Inc.


Financial data and stock pages provided by
Fintel.io